|
|
|
1-10 employees
View all
|
|
biotechnology
|
|
Oakland,California,US
|
|
Modis Therapeutics is a wholly owned subsidiary of Zogenix, Inc. We are focused on developing disease-modifying therapies for rare genetic diseases with high unmet medical need. Our lead program (MT1621) is in clinical development for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease.As a member of the Zogenix family, we arepassionate about taking on the complex challenges of developing therapeutic solutions with the potential to transform the lives of rare disease patients and their families. We strive to make a difference in the lives of these patients, their families, and our employees by operating ethically with the following values: - Compassion - We are driven to improve the lives of others.- Courage - We take action in the face of challenge or ambiguity.- Collaboration - We value the expertise of each individual.- Excellence - We strive to be the best that we can be.And we take pride in being a company that hires exceptional people - like you!
|
Modis Therapeutics (A Zogenix Company) Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Modis Therapeutics (A Zogenix Company) email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Modis Therapeutics (A Zogenix Company) customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.